Kalofonos Isabel insider trades
Kalofonos Isabel has filed 7 Form 4s with the SEC that we hold, for Crinetics Pharmaceuticals, Inc. (CRNX) (Chief Commercial Officer) and IMGN (SVP & CHIEF COMMERCIAL OFFICER). Across all of them we count 0 purchases worth $0 and 1 sale worth $137.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($137.5K). The largest single trade was a sale of 2,500 shares of Crinetics Pharmaceuticals, Inc. worth $137.5K, dated 2026-01-05. The first filing on our record is dated 2023-05-02 and the latest 2026-09-01.
Crinetics Pharmaceuticals, Inc. (CRNX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-05 | S, sale reported on Form 4 | 2,500 | $137.5K | 2026-01-07 |
IMGN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1975163) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms